Physician

Charles M Gremillion, MD

According to 2025 Medicare claims, Charles Gremillion, MD (NPI: 1871572164) practices ophthalmology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is RETINA AND MACULA CONSULTANTS PA (NPI: 1922295641; TIN: 201327973) and primary practice location at 34224-5136.

Gremillion's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,914 traditional Medicare patients, billed 1,594,351 HCPCS/CPT codes, and received $6,689,887 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 716 prescription claims across 257 beneficiaries totaling $45,100 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 15 records totaling $526. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $109,135 to $45,100. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.3M$6.7M2015 Medicare payment: $3,891,860 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,736,190 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,385,410 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,839,773 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,719,859 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,427,769 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,586,789 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,688,337 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,383,832 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,689,887 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,23130,788$3,891,860
20162,34229,139$3,736,190
20172,33623,994$3,385,410
20182,34627,840$3,839,773
20192,28027,934$3,719,859
20202,06922,112$3,427,769
20212,03322,248$3,586,789
20221,98230,941$3,688,337
20231,912336,207$4,383,832
20241,9141,594,351$6,689,887

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$189K$379K2015 Drug cost: $109,135 (USD; Tot_Drug_Cst)2016 Drug cost: $333,080 (USD; Tot_Drug_Cst)2017 Drug cost: $378,536 (USD; Tot_Drug_Cst)2018 Drug cost: $236,528 (USD; Tot_Drug_Cst)2019 Drug cost: $131,478 (USD; Tot_Drug_Cst)2020 Drug cost: $92,964 (USD; Tot_Drug_Cst)2021 Drug cost: $95,876 (USD; Tot_Drug_Cst)2022 Drug cost: $90,792 (USD; Tot_Drug_Cst)2023 Drug cost: $53,730 (USD; Tot_Drug_Cst)2024 Drug cost: $45,100 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015270744$109,135
2016278713$333,080
2017265700$378,536
2018256716$236,528
2019247667$131,478
2020215504$92,964
2021219584$95,876
2022236685$90,792
2023241679$53,730
2024257716$45,100

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye6672,983$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,4912,121$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8691,870$63
92134Imaging of retina1,8194,807$28
92250Photography of the retina1,4472,122$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate25210,867$9,800
LumiganBimatoprost14811$4,682
ProlensaBromfenac Sodium12443$4,210
Ketorolac TromethamineKetorolac Tromethamine492,141$1,766
OfloxacinOfloxacin1112,342$1,177

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$526Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles M. Gremillion, MD?

Tedicare shows public-source Medicare data for Charles M. Gremillion, MD (NPI 1871572164), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles M. Gremillion, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles M. Gremillion, MD?

Charles M. Gremillion, MD is linked to RETINA AND MACULA CONSULTANTS PA (billing NPI 1922295641) in the available physician profile data.

Does Charles M. Gremillion, MD have Open Payments data?

Charles M. Gremillion, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.